Breaking News Instant updates and real-time market news.

GM

General Motors

$38.00

0.315 (0.84%)

, AMTD

TD Ameritrade

$57.57

-1.59 (-2.69%)

10:34
04/09/18
04/09
10:34
04/09/18
10:34

On The Fly: Top five analyst upgrades

Catch up on today's top five analyst upgrades with this list compiled by The Fly: 1. General Motors (GM) upgraded to Overweight from Equal Weight at Morgan Stanley with analyst Adam Jonas saying he sees room for positive earnings revisions for GM, Ford (F) and Fiat Chrysler (FCAU) as investors better understand the impact on U.S. pick-up truck sales from a potential passage of a U.S. infrastructure bill. 2. TD Ameritrade (AMTD) upgraded to Buy from Neutral at BofA/Merrill with analyst Michael Carrier saying he views TD Ameritrade's near-term outlook as attractive given healthy new net asset growth, higher interest rates, and strong DARTs. 3. Comerica (CMA) upgraded to Outperform from Neutral at Wedbush with analyst Peter Winter saying he sees several levers that should drive above average earnings per share growth over the next two years, including margin expansion, potential resumption of loan growth, and above average capital returns. 4. Agilent (A) upgraded to Buy from Neutral at Goldman Sachs with analyst Patrick Donnelly saying he sees an attractive fundamental backdrop across Tools. 5. Discover (DFS) and Ally Financial (ALLY) were upgraded to Equal Weight from Underweight at Stephens. This list is just a portion of The Fly's full analyst coverage. To see The Fly's full Street Research coverage, click here.

GM

General Motors

$38.00

0.315 (0.84%)

AMTD

TD Ameritrade

$57.57

-1.59 (-2.69%)

CMA

Comerica

$96.16

1.24 (1.31%)

A

Agilent

$65.01

1.36 (2.14%)

DFS

Discover

$71.11

0.77 (1.09%)

ALLY

Ally Financial

$27.17

0.55 (2.07%)

  • 11

    Apr

  • 12

    Apr

  • 14

    Apr

  • 17

    Apr

  • 24

    Apr

  • 26

    Apr

  • 26

    Apr

  • 26

    Apr

  • 08

    May

  • 30

    May

  • 12

    Jun

GM General Motors
$38.00

0.315 (0.84%)

04/09/18
04/09/18
NO CHANGE
Target $21

Overweight
Morgan Stanley, bullish on trucks, names American Axle top pick in U.S. Autos
After Morgan Stanley published a report on the potential beneficiaries from infrastructure spending, analyst Armintas Sinkevicius called American Axle (AXL) the supplier with the greatest direct exposure to pick-up trucks and believes it should receive an outsized benefit from any infrastructure spending increase. He named American Axle his top pick in the U.S. Autos & Shared Mobility sector, stating that after the first quarter he expects volumes to improve at General Motors (GM), launch costs to fade and for synergies to provide margin expansion and free cash flow generation. As previously reported, Morgan Stanley analyst Adam Jonas upgraded General Motors to Overweight from Equal Weight this morning, also citing the potential benefits of increased U.S. infrastructure spending.
04/09/18
04/09/18
UPGRADE
Target $48

Overweight
GM upgraded to Overweight on infrastructure bill potential at Morgan Stanley
As previously reported, Morgan Stanley analyst Adam Jonas upgraded General Motors (GM) to Overweight from Equal Weight, as he sees room for positive earnings revisions for GM, Ford (F) and Fiat Chrysler (FCAU) as investors better understand the impact on U.S. pick-up truck sales from a potential passage of a U.S. infrastructure bill. The firm's economics team estimates a bull case of as much as $2.4T in U.S. infrastructure spending over a 10-year period, which primarily would affect automakers through the sale of highly-profitable pickup trucks, said Jonas, who noted that greater infrastructure spending typically does coincide with increased pickup sales. Jonas raised his price target on GM shares to $48 from $45 and increased his price target on Fiat Chrysler to EUR23 from EUR22 per share.
04/09/18
MSCO
04/09/18
UPGRADE
MSCO
Overweight
General Motors upgraded to Overweight from Equal Weight at Morgan Stanley
03/14/18
MSCO
03/14/18
NO CHANGE
MSCO
Morgan Stanley raises U.S. auto sales forecasts through 2021
Morgan Stanley analyst Adam Jonas raised his U.S. seasonally adjusted annual rate, or SAAR, forecast for automakers by an average of 850,000 units from 2018 through 2021, which represents slightly more than a 5% increase from his prior forecast. However, his average U.S. SAAR forecast is still well below last year's 17.3M units and 8% under the cyclical high of 17.6M units in 2016. Jonas points to U.S. tax reform and "relatively stable" recent trends in auto sales and credit as reasons for the hike, noting that while infrastructure action from the federal government could be a material positive, it is not explicitly in his new forecast. Adding that the higher view has a net positive impact on estimates and price targets for exposed auto Original Equipment Manufacturers, or OEMs, and suppliers, Jonas raised his price targets on General Motors (GM), Asbury Automotive (ABG), AutoNation (AN), Group 1 Automotive (GPI), Lithia Motors (LAD), Penske Automotive (PAH), Sonic Automotive (SAH) and Ford (F). He also double upgraded Ford, to Overweight from Underweight, this morning.
AMTD TD Ameritrade
$57.57

-1.59 (-2.69%)

03/06/18
KBWI
03/06/18
UPGRADE
Target $66.5
KBWI
Outperform
Keefe Bruyette upgrades TD Ameritrade, E-Trade on 'compelling' risk/rewards
Keefe Bruyette analyst Kyle Voigt upgraded shares of both TD Ameritrade (AMTD) and E-Trade (ETFC) to Outperform from Market Perform citing "compelling" risk/reward profiles at current levels. The current backdrop of "strong" economic growth, increasing interest rates, high consumer confidence, and recently, a more normalized level of equity market volatility provides a good operating environment for the e-brokers, Voigt tells investors in a research note. Further, he likes the "downside protection" offered by a potential takeout of E-Trade over the next 12 months. The analyst keeps a $66.50 price target on TD Ameritrade and a $61 price target on E-Trade.
04/09/18
BOFA
04/09/18
UPGRADE
Target $66
BOFA
Buy
TD Ameritrade upgraded to Buy on growth, valuation at BofA/Merrill
As previously reported, BofA/Merrill upgraded TD Ameritrade to Buy from Neutral and raised its price target to $66 from $62. Analyst Michael Carrier views TD Ameritrade's near-term outlook as attractive given healthy new net asset growth, higher interest rates, and strong DARTs. Further, the analyst expects the Scottrade acquisition and capital management flexibility to yield further synergy benefits and upside to margins. Carrier views valuation as "attractive" and thinks additional M&A in the sector is likely, which could create more upside for shares.
04/09/18
BOFA
04/09/18
UPGRADE
BOFA
Buy
TD Ameritrade upgraded to Buy from Neutral at BofA/Merrill
04/06/18
RSBL
04/06/18
NO CHANGE
RSBL
Buy
TD Ameritrade estimates continue to move higher, says Rosenblatt
Rosenblatt analyst Chris Allen raised TD Ameritrade's Q2 earnings estimate to $76c from 69c, FY18 to $3.13 from $2.99, and FY19 to $4.00 from $3.82 driven by increased trading volumes and higher rates in the near-term. The analyst sees upside to Street Q2 estimates and looking forward, without even factoring in Scottrade revenue synergies and notes Scottrade customers have already begun to explore Ameritrade option capabilities. Allen reiterated his Buy rating on TD Ameritrade and increased his price target to $65 saying he expects accelerating earnings growth, a solid fundamental backdrop, and improving capital returns to drive shares higher.
CMA Comerica
$96.16

1.24 (1.31%)

03/26/18
NOMU
03/26/18
NO CHANGE
Target $117
NOMU
Buy
Comerica price target raised to $117 from $114 at Nomura Instinet
Nomura Instinet analyst Bill Carcache raised his price target for Comerica to $117 saying the company's "status as a plain vanilla regional bank with underappreciated leverage to higher rates significant excess capital, and high credit quality" positioned its shares to outperform. The analyst increased his earnings growth expectations to reflect higher net interest income and keeps a Buy rating on the shares.
03/27/18
RILY
03/27/18
NO CHANGE
Target $110
RILY
Buy
Comerica price target raised to $110 from $105 at B. Riley FBR
B. Riley FBR analyst Steve Moss raised his price target for Comerica to $110 saying net interest margin expansion, well-controlled expenses, and low credit costs bode well for the earnings outlook. The analyst sees an upward bias to consensus estimates and keeps a Buy rating on Comerica.
04/09/18
04/09/18
UPGRADE
Target $111

Outperform
Comerica upgraded to Outperform at Wedbush
As previously reported, Wedbush analyst Peter Winter upgraded Comerica to Outperform from Neutral and raised his price target on the shares to $111 from $103. The analyst sees several levers that should drive above average EPS growth over the next two years, including margin expansion, potential resumption of loan growth, and above average capital returns. Further, Winter believes Comerica is the standout franchise under his bank coverage with the strongest margin expansion led by the short-term variable nature of its loan portfolio and one of the strongest deposit franchises.
04/09/18
WEDB
04/09/18
UPGRADE
WEDB
Outperform
Comerica upgraded to Outperform from Neutral at Wedbush
A Agilent
$65.01

1.36 (2.14%)

04/09/18
GSCO
04/09/18
UPGRADE
Target $77
GSCO
Buy
Goldman upgrades Agilent to Buy ahead of Q1 earnings season
Goldman Sachs analyst Patrick Donnelly upgraded Agilent Technologies (A) to Buy from Neutral and raised his price target for the shares to $77 from $73. Heading into the Q1 earnings season, the analyst sees an attractive fundamental backdrop across Tools. He believes, however, that the favorable backdrop is well understood by investors with valuations that "remain well-above 10-year highs." The analyst prefers the "idiosyncratic drivers of growth" for Agilent in the out years and views the stock's relative valuation as attractive. He coupled the upgrade with a downgrade of Mettler-Toledo (MTD) to Neutral.
04/09/18
GSCO
04/09/18
UPGRADE
GSCO
Buy
Agilent upgraded to Buy from Neutral at Goldman Sachs
Goldman Sachs analyst Patrick Donnelly upgraded Agilent Technologies to Buy.
01/03/18
EVER
01/03/18
INITIATION
Target $75
EVER
Outperform
Agilent initiated with an Outperform at Evercore ISI
Evercore ISI analyst Ross Muken initiated Agilent with an Outperform and $75 price target.
11/21/17
JPMS
11/21/17
NO CHANGE
Target $75
JPMS
Overweight
Agilent price target raised to $75 from $70 at JPMorgan
JPMorgan analyst Tycho Peterson raised his price target for Agilent Technologies to $75 saying the company's outlook again looks conservative. He expects fiscal 2018 to be "another solid year of beat and raise quarters on both the top and bottom-line." The analyst keeps an Overweight rating on Agilent.
DFS Discover
$71.11

0.77 (1.09%)

04/05/18
04/05/18
INITIATION

On The Fly: Top five analyst initiations
Catch up on today's top five analyst initiations with this list compiled by The Fly: 1. Spotify (SPOT) initiated with a Buy at Canaccord and Stifel. 2. Trade Desk (TTD) initiated with an Overweight at Piper Jaffray. 3. Saul Centers (BFS) initiated with a Neutral at B. Riley FBR. 4. Capital One (COF) and American Express (AXP) were initiated with a Buy at Citi while Discover (DFS) and Synchrony (SYF) were initiated with a Neutral. 5. Intel (INTC) initiated with a Buy at UBS while Qualcomm (QCOM) was initiated with a Neutral. This list is just a portion of The Fly's analyst coverage. To see The Fly's full Street Research coverage, click here.
04/05/18
SBSH
04/05/18
INITIATION
Target $78
SBSH
Neutral
Discover initiated with a Neutral at Citi
Citi analyst Jill Shea started Discover Financial with a Neutral rating and $78 price target.
04/09/18
SPHN
04/09/18
UPGRADE
SPHN
Equal Weight
Discover upgraded to Equal Weight from Underweight at Stephens
04/09/18
04/09/18
UPGRADE

Equal Weight
Ally Financial, Discover upgraded to Equal Weight on valuation at Stephens
As previously reported, Stephens analyst Vincent Caintic upgraded Ally Financial (ALLY) and Discover (DFS), both to Equal Weight from Underweight, as he does not think shares of either have downside from their current levels. He notes Ally shares are down 9% year-to-date, while Discover shares have declined 9% in 2018 as well. Still, he is concerned about U.S. consumer credit broadly and continues to think Discover will underperform relative to the credit card space and that Ally will underperform other auto lenders, Caintic tells investors. He set a $29 price target on Ally shares and a $73 target on Discover.
ALLY Ally Financial
$27.17

0.55 (2.07%)

04/09/18
SPHN
04/09/18
UPGRADE
SPHN
Equal Weight
Ally Financial upgraded to Equal Weight from Underweight at Stephens
01/31/18
WELS
01/31/18
NO CHANGE
Target $35
WELS
Outperform
Ally Financial price target raised to $35 from $30 at Wells Fargo
Wells Fargo analyst Donald Fandetti raised his price target for Ally Financial to $35 from $30 following quarterly results. The analyst reiterates an Outperform rating on the shares.
03/27/18
UBSW
03/27/18
INITIATION
UBSW
Buy
Ally Financial initiated with a Buy at UBS
UBS analyst Eric Wasserstrom initiated Ally Financial with a Buy rating and $33 price target. Wasserstrom believes that Ally's asset mix and funding structure should drive revenue growth, which will improve return on assets and drive price-earnings expansion.

TODAY'S FREE FLY STORIES

AQMS

Aqua Metals

$2.42

0.04 (1.68%)

16:15
08/16/18
08/16
16:15
08/16/18
16:15
Hot Stocks
Aqua Metals CFO Francis Knuettel resigns »

On August 13 Francis…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

16:15
08/16/18
08/16
16:15
08/16/18
16:15
General news
Breaking General news story  »

Week of 8/15 Fed Balance…

16:15
08/16/18
08/16
16:15
08/16/18
16:15
General news
Breaking General news story  »

Week of 8/6 Money Supply…

TSLA

Tesla

$335.46

-3.2 (-0.94%)

16:14
08/16/18
08/16
16:14
08/16/18
16:14
Periodicals
SEC presses Tesla directors for info on communications with Musk, WSJ says »

Federal regulators are…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 29

    Oct

MRK

Merck

$68.85

1.49 (2.21%)

, ESALY

Eisai

$0.00

(0.00%)

16:14
08/16/18
08/16
16:14
08/16/18
16:14
Hot Stocks
Merck, Eisai announce FDA approval of LENVIMA capsules »

Eisai Inc. (ESALY) and…

MRK

Merck

$68.85

1.49 (2.21%)

ESALY

Eisai

$0.00

(0.00%)

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 19

    Aug

  • 24

    Aug

  • 10

    Sep

  • 12

    Sep

  • 03

    Oct

  • 23

    Oct

  • 29

    Oct

  • 16

    Feb

ATGE

Adtalem Global Education

$55.60

-0.4 (-0.71%)

16:13
08/16/18
08/16
16:13
08/16/18
16:13
Earnings
Breaking Earnings news story on Adtalem Global Education »

Adtalem Global Education…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 27

    Sep

ARAY

Accuray

$3.50

0.05 (1.45%)

16:12
08/16/18
08/16
16:12
08/16/18
16:12
Hot Stocks
Accuray CFO Kevin Waters departing October 1, interim CFO appointed »

Accuray CFO Kevin Waters…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 16

    Aug

HDSN

Hudson Technologies

$1.76

-0.07 (-3.83%)

16:12
08/16/18
08/16
16:12
08/16/18
16:12
Hot Stocks
Hudson Technologies receives deficiency letter from Nasdaq »

Hudson Technologie…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

ATGE

Adtalem Global Education

$55.65

-0.35 (-0.63%)

16:11
08/16/18
08/16
16:11
08/16/18
16:11
Earnings
Adtalem Global Education reports Q4 continuing operations EPS 86c, consensus 91c »

Reports Q4 revenue…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 27

    Sep

ARAY

Accuray

$3.50

0.05 (1.45%)

16:11
08/16/18
08/16
16:11
08/16/18
16:11
Earnings
Accuray sees FY19 revenue $415M-$425M, consensus $398.38M »

Sees adjusted…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 16

    Aug

AMAT

Applied Materials

$47.19

-0.3 (-0.63%)

16:11
08/16/18
08/16
16:11
08/16/18
16:11
Hot Stocks
Breaking Hot Stocks news story on Applied Materials »

Applied Materials reports…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 16

    Aug

ATAI

ATA Inc.

$6.80

0.06 (0.89%)

16:09
08/16/18
08/16
16:09
08/16/18
16:09
Hot Stocks
ATA Inc. to acquire Beijing Biztour »

ATA Inc announced that…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

MAT

Mattel

$15.17

-0.11 (-0.72%)

16:08
08/16/18
08/16
16:08
08/16/18
16:08
Hot Stocks
Mattel names Steve Totzke as Chief Commercial Officer »

Mattel announced the…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

AMAT

Applied Materials

$47.25

-0.24 (-0.51%)

16:08
08/16/18
08/16
16:08
08/16/18
16:08
Hot Stocks
Breaking Hot Stocks news story on Applied Materials »

Applied Materials down…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 16

    Aug

JWN

Nordstrom

$52.11

0.25 (0.48%)

16:08
08/16/18
08/16
16:08
08/16/18
16:08
Earnings
Nordstrom raises FY18 EPS view to $3.50-$3.65 from $3.35-$3.55 »

Consensus $3.46. Raises…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 16

    Aug

PFNX

Pfenex

$4.77

0.07 (1.49%)

16:08
08/16/18
08/16
16:08
08/16/18
16:08
Hot Stocks
Pfenex CMO Dr. Hubert Chen resigns »

Pfenex announced that Dr.…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

ARAY

Accuray

$3.50

0.05 (1.45%)

16:07
08/16/18
08/16
16:07
08/16/18
16:07
Earnings
Accuray reports Q4 EPS (1c), consensus (2c) »

Reports Q4 revenue…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 16

    Aug

ICFI

ICF International

$80.65

1.15 (1.45%)

16:07
08/16/18
08/16
16:07
08/16/18
16:07
Hot Stocks
ICF International awarded $20M task order from DHIS »

ICF was recently awarded…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

ZOES

Zoe's Kitchen

$9.48

(0.00%)

16:07
08/16/18
08/16
16:07
08/16/18
16:07
Hot Stocks
Zoe's Kitchen postpones earnings release, conference call until August 17 »

Zoe's Kitchen…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 16

    Aug

JWN

Nordstrom

$52.13

0.27 (0.52%)

16:06
08/16/18
08/16
16:06
08/16/18
16:06
Earnings
Nordstrom reports Q2 EPS 95c, consensus 84c »

Reports Q2 revenue…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 16

    Aug

AMAT

Applied Materials

$47.26

-0.23 (-0.48%)

16:06
08/16/18
08/16
16:06
08/16/18
16:06
Earnings
Applied Materials sees FY18 EPS $4.41-$4.49, consensus $4.59 »

Sees FY18 revenue…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 16

    Aug

EDIT

Editas Medicine

$29.80

0.7 (2.41%)

16:05
08/16/18
08/16
16:05
08/16/18
16:05
Hot Stocks
Editas Medicine announces completion of recombinant DNA committee registration »

Editas Medicine announced…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 12

    Sep

ESRX

Express Scripts

$87.21

0.52 (0.60%)

, CI

Cigna

$187.93

2.48 (1.34%)

16:05
08/16/18
08/16
16:05
08/16/18
16:05
Hot Stocks
Express Scripts urges stockholders to vote in favor of merger with Cigna »

Express Scripts (ESRX)…

ESRX

Express Scripts

$87.21

0.52 (0.60%)

CI

Cigna

$187.93

2.48 (1.34%)

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 24

    Aug

  • 24

    Aug

  • 12

    Sep

AMAT

Applied Materials

$47.39

-0.105 (-0.22%)

16:04
08/16/18
08/16
16:04
08/16/18
16:04
Earnings
Applied Materials sees Q4 EPS 92c-$1.00, consensus $1.17 »

Sees Q4 revenue…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 16

    Aug

AMAT

Applied Materials

$47.39

-0.105 (-0.22%)

16:04
08/16/18
08/16
16:04
08/16/18
16:04
Hot Stocks
Applied Materials CEO says FY18 to deliver double digit grown in all groups »

"While we have seen…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 16

    Aug

Get Full Fly Access

Breaking market intelligence sent straight to you
Our team of experts analyze every news story and filter out the noise to deliver real-time market moving news.
Up-to-date information on important industry events
Get real-time updates on events that are moving the market—from conferences and calls to syndicate announcements.
News focused on the companies in your portfolio
Create up to 12 portfolios with 150 stocks each, and see how active they are in market news.